RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Surgical Science Sweden EBIT 2024

Surgical Science Sweden EBIT

270.07 M SEK

Surgical Science Sweden Dividend yield

Ticker

SUS.ST

ISIN

SE0014428512

WKN

A2P46G

In 2024, Surgical Science Sweden's EBIT was 270.07 M SEK, a 42.78% increase from the 189.15 M SEK EBIT recorded in the previous year.

The Surgical Science Sweden EBIT history

YEAREBIT (undefined SEK)
2029e-
2028e-
2027e-
2026e535.05
2025e389.46
2024e270.07
2023189.15
2022162.54
202156.52
202019.97
201915.18
2018-4.07
2017-4.19
2016-0.23
20151.82
20141.5

Surgical Science Sweden Aktienanalyse

What does Surgical Science Sweden do?

Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Surgical Science Sweden's EBIT

Surgical Science Sweden's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Surgical Science Sweden's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Surgical Science Sweden's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Surgical Science Sweden’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Surgical Science Sweden Stock

How much did Surgical Science Sweden achieve in EBIT for the current year?

In the current year, Surgical Science Sweden has achieved an EBIT of 270.07 M SEK.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Surgical Science Sweden.

How has the EBIT of Surgical Science Sweden developed in recent years?

The EBIT of Surgical Science Sweden has increased by 42.779% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Surgical Science Sweden?

The EBIT of Surgical Science Sweden is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Surgical Science Sweden pay?

Over the past 12 months, Surgical Science Sweden paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surgical Science Sweden is expected to pay a dividend of 0 SEK.

What is the dividend yield of Surgical Science Sweden?

The current dividend yield of Surgical Science Sweden is .

When does Surgical Science Sweden pay dividends?

Surgical Science Sweden pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surgical Science Sweden?

Surgical Science Sweden paid dividends every year for the past 0 years.

What is the dividend of Surgical Science Sweden?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surgical Science Sweden located?

Surgical Science Sweden is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surgical Science Sweden kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surgical Science Sweden from 5/18/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 5/18/2024.

When did Surgical Science Sweden pay the last dividend?

The last dividend was paid out on 5/18/2024.

What was the dividend of Surgical Science Sweden in the year 2023?

In the year 2023, Surgical Science Sweden distributed 0 SEK as dividends.

In which currency does Surgical Science Sweden pay out the dividend?

The dividends of Surgical Science Sweden are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Surgical Science Sweden

Our stock analysis for Surgical Science Sweden Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgical Science Sweden Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.